{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:20:42Z","timestamp":1774113642833,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.beem.2019.101318","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T10:58:57Z","timestamp":1567249137000},"page":"101318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1"],"prefix":"10.1016","volume":"33","author":[{"given":"Max B.","family":"Albers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerena","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef K.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2019.101318_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.beem.2019.101318_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2019.101318_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2019.101318_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.beem.2019.101318_bib5","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101318_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2019.101318_bib7","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101318_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0016-5085(99)70124-1","article-title":"Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE)","volume":"116","author":"Cadiot","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2019.101318_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.beem.2019.101318_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib11","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1210\/jc.2017-00372","article-title":"Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 study group","volume":"102","author":"Pieterman","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101318_bib12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1159\/000443613","article-title":"Active surveillance versus surgery of nonfunctioning pancreatic neuroendocrine neoplasms <\/=2 cm in MEN1 patients","volume":"103","author":"Partelli","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2019.101318_bib13","article-title":"Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: a GTE and AFCE Cohort Study (Groupe d'etude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne)","author":"Vinault","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00535-016-1250-9","article-title":"Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan","volume":"52","author":"Ito","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.beem.2019.101318_bib15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3748\/wjg.v17.i10.1343","article-title":"Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients","volume":"17","author":"Imamura","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.beem.2019.101318_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2019.101318_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00000658-200110000-00009","article-title":"Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome","volume":"234","author":"Norton","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SLA.0b013e3182536339","article-title":"Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1","volume":"257","author":"Lopez","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib19","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.3748\/wjg.v12.i34.5440","article-title":"Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features","volume":"12","author":"Anlauf","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.beem.2019.101318_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1053\/j.gastro.2005.01.058","article-title":"Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas","volume":"128","author":"Anlauf","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2019.101318_bib21","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2019.101318_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2796.1998.00307.x","article-title":"Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both","volume":"243","author":"Thompson","year":"1998","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2019.101318_bib23","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0016-5085(95)90124-8","article-title":"Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study","volume":"108","author":"Weber","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2019.101318_bib24","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1210\/jcem.86.11.8011","article-title":"Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form","volume":"86","author":"Gibril","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101318_bib25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/PAS.0b013e3181655811","article-title":"Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor","volume":"32","author":"Anlauf","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beem.2019.101318_bib26","doi-asserted-by":"crossref","first-page":"E2387","DOI":"10.1210\/jc.2013-4432","article-title":"Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain","volume":"99","author":"Bartsch","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101318_bib27","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddt039","article-title":"Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study","volume":"22","author":"Thevenon","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2019.101318_bib28","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.3748\/wjg.v18.i39.5495","article-title":"Diagnosis of Zollinger-Ellison syndrome: increasingly difficult","volume":"18","author":"Ito","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.beem.2019.101318_bib29","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00268-017-3907-9","article-title":"Limited value of Ga-68-DOTATOC-PET-CT in routine screening of patients with multiple endocrine neoplasia type 1","volume":"41","author":"Albers","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2019.101318_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT","volume":"247","author":"Norton","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00006676-198804000-00006","article-title":"Long-acting somatostatin (SMS 201-995) in the management of Zollinger-Ellison syndrome: evidence for sustained efficacy","volume":"3","author":"Ruszniewski","year":"1988","journal-title":"Pancreas"},{"key":"10.1016\/j.beem.2019.101318_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0026-0495(92)90044-B","article-title":"Gastroenteropancreatic endocrine tumors: effect of Sandostatin on tumor growth. The German Sandostatin Study Group","volume":"41","author":"Arnold","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2019.101318_bib33","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2169\/internalmedicine.49.3607","article-title":"Long-term suppressive effect of octreotide on progression of metastatic gastrinoma with multiple endocrine neoplasia type 1: seven-year follow up","volume":"49","author":"Yamaguchi","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.beem.2019.101318_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199409000-00008","article-title":"Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma","volume":"220","author":"Fraker","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.sla.0000218073.77254.62","article-title":"Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias","volume":"244","author":"Tonelli","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib36","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.surg.2011.09.028","article-title":"Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important","volume":"150","author":"Dickson","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2019.101318_bib37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jamcollsurg.2006.02.013","article-title":"50-year appraisal of gastrinoma: recommendations for staging and treatment","volume":"202","author":"Ellison","year":"2006","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.beem.2019.101318_bib38","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000189549.51913.d8","article-title":"Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1","volume":"242","author":"Bartsch","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib39","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1210\/jc.2007-0283","article-title":"Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome","volume":"92","author":"Schott","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101318_bib40","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00268-004-7345-0","article-title":"Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas","volume":"28","author":"Richards","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2019.101318_bib41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1200\/JCO.1999.17.2.615","article-title":"Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome","volume":"17","author":"Yu","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2019.101318_bib42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF01655105","article-title":"Surgical treatment of the Zollinger-Ellison syndrome","volume":"17","author":"Stadil","year":"1993","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2019.101318_bib43","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bpg.2005.05.003","article-title":"Surgical treatment and prognosis of gastrinoma","volume":"19","author":"Norton","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.beem.2019.101318_bib44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000143252.02142.3e","article-title":"Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome","volume":"240","author":"Norton","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib45","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0039-6060(05)80102-3","article-title":"Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1","volume":"118","author":"MacFarlane","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2019.101318_bib46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.surg.2009.06.038","article-title":"Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms","volume":"146","author":"Gauger","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2019.101318_bib47","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00268-018-4809-1","article-title":"Results of duodenopancreatic reoperations in multiple endocrine neoplasia type 1","volume":"43","author":"Albers","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2019.101318_bib48","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00423-001-0274-6","article-title":"Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1","volume":"386","author":"Akerstrom","year":"2002","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.beem.2019.101318_bib49","first-page":"402","article-title":"What extent of pancreatic resection do patients with MEN-1 require?","volume":"13","author":"Adkisson","year":"2012","journal-title":"JOP"},{"key":"10.1016\/j.beem.2019.101318_bib50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.surg.2007.09.010","article-title":"Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: operative outcomes, long-term function, and quality of life","volume":"142","author":"You","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2019.101318_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00268-004-7585-z","article-title":"New pancreas-preserving total duodenectomy technique","volume":"29","author":"Imamura","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2019.101318_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00423-017-1625-2","article-title":"Postoperative outcome and quality of life after surgery for FAP-associated duodenal adenomatosis","volume":"403","author":"Ganschow","year":"2018","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.beem.2019.101318_bib53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0039-6060(05)80198-9","article-title":"Pancreas-sparing duodenectomy: indications, surgical technique, and results","volume":"117","author":"Chung","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2019.101318_bib54","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00268-016-3456-7","article-title":"Minimally invasive versus open pancreatic surgery in patients with multiple endocrine neoplasia type 1","volume":"40","author":"Lopez","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2019.101318_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17474124.2017.1253473","article-title":"Systematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs)","volume":"11","author":"Tamburrino","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.beem.2019.101318_bib56","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jso.24315","article-title":"Robot-assisted spleen preserving pancreatic surgery in MEN1 patients","volume":"114","author":"Nell","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.beem.2019.101318_bib57","article-title":"Laparoscopic resection of duodenal carcinoid: a feasible method: single institute case series","author":"Dhaduk","year":"2018","journal-title":"J\u00a0Minimal Access Surg"},{"key":"10.1016\/j.beem.2019.101318_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrgastro.2016.17","article-title":"Laparoscopic pancreatic surgery for benign and malignant disease","volume":"13","author":"de Rooij","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.beem.2019.101318_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jgh.12390","article-title":"Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study","volume":"29","author":"Kim","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.beem.2019.101318_bib60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000459404","article-title":"Early gastroenteropancreatic neuroendocrine tumors: endoscopic therapy and surveillance","volume":"33","author":"Scherubl","year":"2017","journal-title":"Visc Med"},{"key":"10.1016\/j.beem.2019.101318_bib61","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","article-title":"Proton pump inhibitors: review of emerging concerns","volume":"93","author":"Nehra","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beem.2019.101318_bib62","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0016-5085(92)90157-T","article-title":"Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome","volume":"102","author":"Pisegna","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2019.101318_bib63","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00423-011-0828-1","article-title":"Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1","volume":"396","author":"Lopez","year":"2011","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.beem.2019.101318_bib64","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0039-6060(96)80055-9","article-title":"Is reoperation for gastrinoma excision indicated in Zollinger-Ellison syndrome?","volume":"120","author":"Jaskowiak","year":"1996","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2019.101318_bib65","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/SLA.0000000000002122","article-title":"Prospective evaluation of results of reoperation in Zollinger-Ellison syndrome","volume":"267","author":"Norton","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101318_bib66","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4158\/EP161639.OR","article-title":"Prognostic factors for survival of Men 1 patients with duodenopancreatic tumors metastatic to the liver: results from the Dmsg","volume":"23","author":"Conemans","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2019.101318_bib67","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","article-title":"Recommendations for management of patients with neuroendocrine liver metastases","volume":"15","author":"Frilling","year":"2014","journal-title":"Lancet Oncol"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19300697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19300697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:54:40Z","timestamp":1761497680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X19300697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1521690X19300697"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2019.101318","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2019.101318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101318"}}